An official website of the United States government
The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before
sharing sensitive information, make sure you’re on a federal
government site.
The site is secure.
The https:// ensures that you are connecting to the
official website and that any information you provide is encrypted
and transmitted securely.
1 The Ronald O. Perelman Department of Dermatology, NYU Grossman School of Medicine, New York, New York.
2 Department of Psychiatry and Behavioral Sciences, The University of Miami Miller School of Medicine, Miami, Florida; Department of Population Health, NYU Grossman School of Medicine, New York, New York; Department of Psychiatry, NYU Grossman School of Medicine, New York, New York.
3 Department of Population Health, NYU Grossman School of Medicine, New York, New York; The Laura and Isaac Perlmutter Cancer Center, NYU Langone Health, New York, New York.
4 The Laura and Isaac Perlmutter Cancer Center, NYU Langone Health, New York, New York; Department of Surgery, NYU Grossman School of Medicine, New York, New York.
5 The Ronald O. Perelman Department of Dermatology, NYU Grossman School of Medicine, New York, New York; The Laura and Isaac Perlmutter Cancer Center, NYU Langone Health, New York, New York. Electronic address: David.Polsky@nyulangone.org.
1 The Ronald O. Perelman Department of Dermatology, NYU Grossman School of Medicine, New York, New York.
2 Department of Psychiatry and Behavioral Sciences, The University of Miami Miller School of Medicine, Miami, Florida; Department of Population Health, NYU Grossman School of Medicine, New York, New York; Department of Psychiatry, NYU Grossman School of Medicine, New York, New York.
3 Department of Population Health, NYU Grossman School of Medicine, New York, New York; The Laura and Isaac Perlmutter Cancer Center, NYU Langone Health, New York, New York.
4 The Laura and Isaac Perlmutter Cancer Center, NYU Langone Health, New York, New York; Department of Surgery, NYU Grossman School of Medicine, New York, New York.
5 The Ronald O. Perelman Department of Dermatology, NYU Grossman School of Medicine, New York, New York; The Laura and Isaac Perlmutter Cancer Center, NYU Langone Health, New York, New York. Electronic address: David.Polsky@nyulangone.org.
This Melanoma Health Equity Framework centers around race and ethnicity. The inner gray…
Fig 1.
This Melanoma Health Equity Framework centers around race and ethnicity. The inner gray circles represent how individual, community, and structural level social determinants of health interact to impact care. The outer 13 colored circles denote barriers to the 3 steps in the pathway in care: (1) blue corresponds to barriers to awareness of concerning skin lesions and melanoma risk; (2) purple corresponds to access and medical assessment; and (3) green corresponds to acceptance of and adherence to treatment and/or follow up recommendations. Although certain barriers may be more likely to impact specific aspects of care (ie, lack of melanoma knowledge impacts overall awareness), it is important to note that these barriers also influence other aspects of care (ie, lack of melanoma knowledge may result in decreased understanding of the importance of timely treatment and act as a barrier to follow-up care). Circles shaded in multiple colors highlight how these barriers can impact multiple aspects of the care pathway.
Reyes-Ortiz CA, Goodwin JS, Freeman JL, Kuo YF. Socioeconomic status and survival in older patients with melanoma. J Am Geriatr Soc. 2006;54(11):1758–1764.
-
PMC
-
PubMed
Qian Y, Johannet P, Sawyers A, Yu J, Osman I, Zhong J. The ongoing racial disparities in melanoma: an analysis of the Surveillance, Epidemiology, and End Results database (1975–2016). J Am Acad Dermatol. 2021;84(6):1585–1593.
-
PMC
-
PubMed
Harvey VM, Patel H, Sandhu S, Wallington SF, Hinds G. Social determinants of racial and ethnic disparities in cutaneous melanoma outcomes. Cancer Control. 2014;21(4):343–349.
-
PMC
-
PubMed
Pollitt RA, Clarke CA, Swetter SM, Peng DH, Zadnick J, Cockburn M. The expanding melanoma burden in California hispanics: importance of socioeconomic distribution, histologic subtype, and anatomic location. Cancer. 2011;117(1):152–161.
-
PMC
-
PubMed
Andrews A Treating with checkpoint inhibitors—figure $1 million per patient. Am Health Drug Benefits. 2015;8(Spec Issue):9.
-
PMC
-
PubMed